Author

Foivos Irakleidis

Observed names: F Irakleidis, F. Irakleidis, I. Foivos

Observed institutions: Guy's Hospital, St Thomas' Hospital, Royal Marsden NHS Foundation Trust, Royal Free London NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, The Royal Free Hospital, General Hospital of Rhodes, University College London

ORCID: 0000-0002-6569-1266

Observed ORCID: 0000-0002-6569-1266

OpenAlex ID: A5075705894

Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction

2020 · S Potter, A Trickey, et al. · British journal of surgery · 41

PDF

Complex interaction of adiponectin-mediated pathways on cancer treatment: a novel therapeutic target

2019 · Massimo Monks, Foivos Irakleidis, et al. · Journal of Cancer Metastasis and Treatment · 9

PDF

Aberrant right subclavian artery – a rare congenital anatomical variation causing dysphagia lusoria

2020 · Foivos Irakleidis, Jonathon Kyriakides, et al. · VASA · 6

P049: The prognostic role of Ki-67 in relation to Oncotype DX Recurrence Score

2025 · C. Markopoulos, A. Koumarianou, et al. · The Breast · 1

“no Drain” and Day-case Mastectomy and Axillary Surgery: Our Experience

2021 · Eleftherios Sfakianakis, Foivos Irakleidis, et al. · Mastology · 1

PDF

Encysted Papillary Carcinoma of the Breast (EPC): A Follow-up Study to Investigate the Role of Sentinel Lymph Node Biopsy

2020 · Ioannis Spyrou, Foivos Irakleidis, et al. · Archives of Breast Cancer · 1

A Greek Real-World Experience With the Implementation of the EndoPredict Gene Signature in a Cohort of Pre-menopausal and Post-menopausal Patients With ER+/HER2- Breast Cancer

2026 · George Pantazidis, Antigoni Sourla, et al. · Cureus

Abstract PS3-09-14: Caught in the Middle: Discrepancies Between Immunohistochemistry and Oncotype DX in Hormone Receptor Assessment Leading to Triple Negative Reclassification—Tumour Heterogeneity or Just Low ER Expression?

2026 · V. Angelis, A. Grobbelaar, et al. · Clinical Cancer Research

P437: Discrepancies in the assessment of oestrogen and progesterone receptor status using immunohistochemistry and OncotypeDX; reclassification to triple negative breast cancer and implications in treatment

2025 · F. Irakleidis, M. Warren, et al. · The Breast

O092 SRC intervention for treating breast cancer

2023 · A Abdulhadi, F Irakleidis, et al. · British journal of surgery

PDF

Bilateral metachronous inflammatory breast cancer. A rare case of this biologically aggressive breast cancer subtype.

2022 · Ashutosh Kothari, Foivos Irakleidis, et al. · European Journal of Surgical Oncology

Patient-Derived Fibroblasts (PDF) Display Differential Responses to Drug Inhibition

2022 · Foivos Irakleidis, Ali Behbehani, et al. · European Journal of Surgical Oncology

82P Predicting invasive disease and lymph node involvement in patients with preoperative diagnosis of ductal carcinoma in situ

2021 · A.A. Tondare, F. Irakleidis, et al. · Annals of Oncology

Breast cancer surgery in COVID19 outbreak: the role of therapeutic mammoplasty

2021 · E. Sfakianakis, P. Tan, et al. · The Breast

Management of the Axilla in Patients With Breast Cancer and One Out of One Positive Sentinel Lymph Node. Can We Omit Axillary Lymph Node Clearance?

2021 · Foivos Irakleidis, Ashutosh Tondare, et al. · Mastology

PDF

Modified Slow Digestion Technique for the Isolation of Patient-derived Cells: an in Vitro Model for the Design of Breast Cancer-associated Stroma

2021 · Foivos Irakleidis, Michael Masucci, et al. · Mastology

PDF

Clinical Significance of Breast Density: Is There Any Need for Supplemental Screening?

2021 · Eleftherios Sfakianakis, Foivos Irakleidis, et al. · Mastology

PDF

The impact of neoadjuvant chemotherapy on re-excision rates after breast-conserving surgery

2018 · Marios Konstantinos Tasoulis, Pooja Padmanabhan, et al. · European Journal of Surgical Oncology

Works count: 18

Citation count: 59

H-index: 3

I10-index: 1